Name

Smartway Pharmaceuticals

Legal name

Smartway Pharmaceuticals Limited

Website

https://smartwaypharma.co.uk

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

251–500 employees

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution and Wholesale

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210), Drugs and Druggists' Sundries Merchant Wholesalers (42421), Pharmaceutical Preparation Manufacturing (325412), Pharmacies and Drug Retailers (456110), Pharmaceutical and Medicine Manufacturing (32541), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (42345)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Pharmaceutical Preparations (2834), Retail-Drug Stores And Proprietary Stores (5912), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Specialty Pharmaceutical Distributors (HLAIAJAB)

akta.pro secondary industry

Compounding Pharmacies (Sterile/Non-Sterile) (HLAFALAE)

Keywords

• Pharmaceutical wholesale
• Pharmaceutical distribution
• Unlicensed medicines supply
• Early access programs
• Comparator drug supply

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices7 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Distribution & Wholesale: Core revenue from global distribution and wholesale of branded and generic pharmaceuticals, unlicensed medicines, specials, and imported medicines. Revenue generated through procurement and supply of pharmaceuticals to healthcare providers, hospitals, pharmacies, and wholesalers across 98 countries.
2. Early Access Programs (EAP): Design, implementation and global management of Expanded Access, Early Access, Compassionate Use and Named Patient Programs for pharma and biotech companies. Services include regulatory strategy, program design, global supply chain, and real world data collection.
3. Comparator/RLD Supply: Supply of comparators, RLDs (Reference Listed Drugs), samples and biosimilar samples to manufacturers, CROs and CDMOs for clinical trials. Global supply chain built over 30 years with direct manufacturer relationships.
4. Sexual Health Supply: Specialist distribution of contraceptive medicines and disposable instruments. Includes over 500 pharmaceutical and medical device products, over-labelling services, and bespoke kitting services.
5. Market Access & Product Commercialisation: In-licensing and product selection, regulatory strategy and execution, licensed supply and commercial launch, lifecycle and portfolio management. Structured inward licensing arrangements supporting regulatory approval and MAH-based commercialisation.

Go-to-market motion3 records

Distribution channels7 records

Marketing channels7 records

Core offering

Smartway Pharmaceuticals is a global pharmaceutical wholesaler and distributor that sources and supplies branded, generic, unlicensed, shortage, specials, imported and controlled medicines to healthcare professionals, hospitals, pharmacies, pharma and biotech companies, wholesalers and aid organisations across 98 countries. The company also designs and manages Early Access Programs (Expanded Access, Compassionate Use and Named Patient Programs), supplies comparator drugs and reference listed drugs for clinical trials, and operates an online pharmacy for private prescriptions.

Product overview

Smartway Pharmaceuticals operates as a global pharmaceutical wholesaler and distributor offering a comprehensive portfolio of products and services. The company provides both digital platforms and service offerings. Key digital products include SmartMed (portal for unlicensed medicines information), SmartRx (e-prescribing platform), and SMARThub (EAP management system). Service offerings span Early Access Programs, Hospital & Pharmacy Supply, Aid & Development, Comparator/RLD Supply, Sexual Health Supply (Smartway Sexual Health), Specialist Distribution, International Supply & Unlicensed Imports, and Market Access & Product Commercialisation. The company leverages distribution hubs in the EU, UK, Dubai, India, and USA to serve healthcare professionals, pharmaceutical companies, wholesalers/distributors, aid organisations, and patients across 98 countries.

Differentiator

Problem solved

Functional benefit

Brands

• SmartMed: Digital portal for unlicensed medicines providing quick access to product documentation, batch-specific data, support materials, market shortage updates, and API disruption information for hospital pharmacists, technicians, and clinicians.
• SmartRx

Products and services

• Early Access Programs (EAP) Global programs that empower access to innovative therapies before commercial launch. Smartway designs, implements, and manages Expanded Access, Early Access, Compassionate Use and Named Patient Programs across 98 countries in partnership with pharma and biotech companies. Services include regulatory strategy, program design, global supply chain, and real-world data collection.
• Hospital & Pharmacy Supply

Quantifiable outcome

• 5 million packs shipped globally in last 5 years
• +4 more outcomes

Named customers7 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Seven partnerships are on record, tiered core and supporting.

• Marius PharmaceuticalscoreStrategic or Co-development Partner · 10 August 2023Strategic partnership for global Early Access Program for KYZATREX™ (testosterone undecanoate) addressing global issue of hypogonadism. Smartway designs and manages comprehensive EAP to enable access to therapies before commercially launched.
• Ambrose HealthcarecoreStrategic or Co-development Partner · 3 May 2023Partnership for international Early Access Programs for Ambrose products treating rare diseases. Smartway serves as exclusive supplier of end-to-end EAP services including regulatory design and submission, and global compliant distribution of therapeutics under international EAPs. Ambrose Healthcare is a specialist pharmaceutical company addressing unmet medical needs in rare disease.
• Thyroid UKsupportingOthersCharity partnership to help patients access thyroid medications. Smartway works with Thyroid UK to ensure patients can access their needed medicine through pharmacies and wholesalers.
• NHScoreChannel Partner/ Reseller/ DistributorNHS approved supplier for over 25 years. Supplies unlicensed imports and specials to all UK NHS Trusts. Partnered with NHS on medicine waste reduction through breakdown and repackaging of medicines.
• UK Department of HealthsupportingChannel Partner/ Reseller/ DistributorWorking with UK Department of Health on medicine shortage challenges including importing unlicensed medicines to ensure patient access.
• UK Non-profit Sexual Health OrganizationssupportingChannel Partner/ Reseller/ DistributorPartnership with one of the largest non-profit organisations in the UK for providing contraceptive methods. Smartway provides comprehensive range of contraceptive medicines to support healthcare providers.
• UN Sustainable Development GoalssupportingOthersAdopted relevant UN Sustainable Development Goals. Initial focus on Goal 3 (Good Health and Wellbeing) through access to medicines globally. Committed to carbon neutral programs including charitable tree planting projects for carbon capture.

Scale indicators11 records

Recent moves12 records

Expansion highlights5 records

Direct peers

• Alliance Healthcare: UK's largest pharmaceutical wholesaler and distributor, supplying independent pharmacies, hospitals, and clinics across the UK and Europe. Directly comparable as a UK-headquartered pharma wholesaler competing for NHS framework agreements and hospital pharmacy contracts, though at significantly larger scale than Smartway.
• Clinigen Group: Global pharmaceutical services company specialising in Managed Access (Early Access/Named Patient) Programs, unlicensed medicine supply, and clinical trial supply. The closest direct competitor to Smartway's EAP, Comparator/RLD, and unlicensed medicines service lines, with overlapping customer base of pharma/biotech manufacturers.
• Durbin PLC: UK-based specialist pharmaceutical wholesaler and distributor focused on unlicensed medicines, clinical trial supply, and named-patient programs. Closely comparable to Smartway in scale and service mix — both serve NHS Trusts and pharma manufacturers with shortage, unlicensed, and comparator supply from UK bases.
• Mawdsleys: UK specialist pharmaceutical distributor providing wholesale, unlicensed medicines, and pharmacy services to NHS Trusts and the broader healthcare market. Comparable to Smartway's hospital/pharmacy supply business with similar UK regulatory positioning and NHS framework participation.
• Lexon UK: UK pharmaceutical wholesaler and parallel distributor specialising in unlicensed and imported medicines, with NHS framework participation. Closely comparable to Smartway's International Supply & Unlicensed Imports service line and shortage-response capability.
• IDIS Group (now part of Norgine): Specialist pharmaceutical company historically focused on named-patient/managed access programs and unlicensed medicine supply in Europe. Comparable to Smartway's EAP and unlicensed medicines operations with similar regulatory-driven service model and pharma/biotech customer base.

Broad incumbents

• McKesson Europe (Lloyds Pharmacy Healthcare): One of the world's largest pharmaceutical wholesalers and distributors, with deep UK/European footprint through Lloyds Pharmacy and AAH Pharmaceuticals. Comparable as a full-line pharma wholesaler serving hospitals, pharmacies, and manufacturers, though operating at much greater scale across a broader portfolio.
• Phoenix Group: Leading European pharmaceutical distribution company operating across 27+ countries with comprehensive wholesale, retail pharmacy, and pharma services businesses. Comparable as a continental pharma wholesaler with hospital pharmacy services, though with materially larger geographic and SKU coverage than Smartway.
• Alcura (Walgreens Boots Alliance): Specialist pharmaceutical services business within Walgreens Boots Alliance focused on clinical trial supply, homecare, and patient access services. Comparable to Smartway's Comparator/RLD supply and EAP/Market Access lines, though operating as part of a much larger parent group.
• Cencora (formerly AmerisourceBergen): One of the largest global pharmaceutical distributors and services providers, with specialty distribution and clinical trial supply capabilities (through World Courier and PharmaLex-adjacent offerings). Comparable to Smartway in pharma distribution and global reach, but operating at vastly greater scale with deep manufacturer partnerships.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/smartway-pharmaceuticals
• Xx.com/smartwaypharma
• Facebookfacebook.com/smartwaypharmaceuticals

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Smartway Pharmaceuticals